ARCHIVES

FDA Proposes New User Fees for Generics and Biosimilar Products

This article is from The Cancer Letter archive.

Vol. 38 No. 03 | January 20, 2012

Download PDF Visit The Full Archive

Related Articles

Minimally Invasive Radiation Said To Preserve Functions

April 24, 2009

Estrogen-Only HRT Little Risk In Endometrial Cancer, GOG Study Indicates

March 26, 2004

DCT Program Cutbacks Planned as Research Stressed In 4 Cancers

February 26, 1993

Cancer Control: Incidence, Death Rates Continue To Fall, Annual Reports Says

April 23, 1999

Private Sector Still Valuable To National Cancer Program, ACS Research Chief Says

April 26, 1974

Center And Cooperative Group Clinical Trials Approved By NCI

May 27, 2005